Filter Search


Healthcare-and-Medical


Location Summary Deadline
India Supply Of Periodontics Books, Conservative Endodontics Books, Orthodontics Books, Microbiology Books, Biochemistry Books, Prosthodontics Books, Physiology Books, General Surgery Books, Oral Pathology Microbiology Books, Public Helath Dentistry Books, Phar 2025-07-24
Portugal Acquisition Of 2022_10 Therapeutic Effect For The Therapeutic Effect For Ulsasi For The Year 2025 contract Date: : 24-04-2025 contract Price: 18.045,68 € deadline: 251 Dias place Of Execution: Portugal, Lisboa, Amadora.acquisition Of 2022_10 Therapeutic E 2025-07-24
Slovenia Contract Awarded For: Buy A Robotic System For Preparing, Storing And Distributing Medicines For Sb Ce Pharmacy .buy A Robotic System For Preparing, Storing And Distributing Medicines For Sb Ce Pharmacy 2025-07-24
Slovenia Contract Awarded For: Reagents And Consumables For Immunohematological Testing Of Blood Donors, Patients And Archiving Samples .reagents And Consumables For Immunohematological Testing Of Blood Donors, Patients And Archiving Samples 2025-07-24
Slovenia Contract Awarded For: Purchase Of Dental Material .purchase Of Dental Material 2025-07-24
Slovenia Contract Awarded For: Laboratory Material And Reagents_sklop 14 .laboratory Material And Reagents_sklop 14 2025-07-24
Slovenia Contract Awarded For: Orthopedic Endoprostheses And Implants - A Recurrence .orthopedic Endoprostheses And Implants - A Recurrence 2025-07-24
Portugal Return To Portugal Of The Future 2025 contract Date :: 24-04-2025 contract Price: 25,000.00 € deadline: 4 Days place Of Execution: Portugal, Leiria, Ansião.return To Portugal Of The Future 2025 2025-07-24
Spain Contract Awarded For Supply Of Original And Biosimilar Biological Pharmaceutical Specialties Based On The Following Active Ingredients: Adalimumab, Trastuzumab, Etanercept, Rituximab, Inflicimab And Bevacizumab For Hospitals In The Zaragoza I. (lot 2) bid 2025-07-24
Spain Contract Awarded For Supply Of Original And Biosimilar Biological Pharmaceutical Specialties Based On The Following Active Ingredients: Adalimumab, Trastuzumab, Etanercept, Rituximab, Inflicimab And Bevacizumab For The Pharmacy Service Of The Hospitals Of 2025-07-24
Whats app